Critical Care

official impact factor 4.60

Open Access Research

Marked increase of procalcitonin after the administration of anti-thymocyte globulin in patients before hematopoietic stem cell transplantation does not indicate sepsis: a prospective study

Helena Brodska, Tomas Drabek, Karin Malickova, Antonin Kazda, Antonin Vitek, Tomas Zima and Marketa Markova*

Critical Care 2009, 13:R37 doi:10.1186/cc7749


See related commentary by McLean, http://ccforum.com/content/13/3/149

No comments have yet been made on this article.

Post a comment